🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
LLY
NYSE
🇺🇸 US
Eli Lilly and Company
Pharmaceuticals
17Score
DipBuster Score™
$1,098.57
$13.43 (-1.21%)
Live price · Source: Yahoo
52-Week Position
$623.78
85% of range
$1,182.73
Beta
0.517
Low vol
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.517
52W High$1,182.73
52W Low$623.78
🤖
Not a Dip — Score 17/100
Zone: Consider Trimming
🔒 Unlock Pro
Valuation
P/E Ratio—
Mkt CapN/A
52W Position85% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.517
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️
Insider Buys
Track director & CEO open-market purchases
📊
Valuation Analysis
P/E, EV/EBITDA, DCF & NCAV metrics
📈
Financial Charts
Revenue, EBITDA, FCF & balance sheet trends
🤖
AI Analysis
Plain-English explanation of every key metric
Sign up free — charts & fundamentals included
Get financial charts, valuation data, dividends & news for Eli Lilly and Company free. Upgrade to Pro for insider signals & AI analysis.
Sponsored · FCA Regulated Broker
Freetrade
Simple investing app. Free ISA. UK and US stocks. FCA regulated.
Free share when you fund your account
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
6/25
Momentum & Volume
6/25
Quality & Size
5/10
Insider Activity
0/10
Quick Take
⚪
Not a Dip
DipBuster Score: 17/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
Eli Lilly and Company is a prominent global pharmaceutical firm dedicated to the research, development, and commercialization of human medicines across the world. Its therapeutic offerings include a comprehensive suite o…
Sector
Pharmaceuticals
Market
🇺🇸 US
CEO
David A. Ricks
Staff
47,000 employees
Website